May 19, 2017
Decibel Therapeutics relocated its headquarters and lab space into Samuels & Associates’ Van Ness mixed-use development in Boston’s Fenway neighborhood. The biotech company took 32,000 square feet at 1325 Boylston St., which signals a broader shift in The Fenway’s transformation.
Decibel, which is developing hearing loss treatments, is the first biotech company to move into the area, joining a burgeoning health and technology hub.
Samuels & Associates’ Peter Sougarides says, “Decibel’s headquarters and lab really mark a tipping point for health innovation companies falling in love with The Fenway.”
Van Ness, which opened in summer 2015, consists of a 172-unit residential tower and a 237,000-square-foot office tower atop a 165,000-square-foot retail base.
Decibel Therapeutics’ Steve Holtzman said, “Our new headquarters in The Fenway will enable us to bring our capabilities under one roof, and sustain the cross-disciplinary exchange needed to conduct breakthrough science, while supporting our growth.”
For comments, questions or concerns, please contact Dennis Kaiser